• Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

  • Jul 19 2023
  • Length: 1 hr and 5 mins
  • Podcast
Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics By cover art

Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

Listen for free

View show details

  • Summary

  • Today I am talking to Eliot Forster xCEO of F-star Therapeutics.
    Eliot was at helm of the company as they reversed merged into Springbank Pharmaceuticals & through the recently announced acquisition by Sino Biopharma, a transaction that generated a lot of interest given the very public interactions with CFIUS.
    Prior to F-star, Eliot was CEO of Immunocore, Creabilis and Solace Pharmaceuticals following his multiple roles at Pfizer which included head of development and operations, European Union. He was the founding chair of Medcity and is an honorary visiting professor of molecular and clinical cancer medicine at the University of Liverpool, to name just a few roles he has had. Eliot is a member of the board of directors of Immatics and is chair of the boards of Ochre Biosciences and Avacta.
    Show more Show less
Show more Show less

What listeners say about Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available